HIV among drug users at beth israel medical center, new york city, the first 25 years

Substance Use and Misuse

Volumn 46, Issue 2-3, 2011, Pages 131-139

  Des Jarlais, Don C ^a,b   Arasteh, Kamyar ^a   Friedman, Samuel R ^b  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

Author keywords

HIV epidemic; HIV AIDS; injection drug use; New York City

Indexed keywords

ARTICLE; DISEASE TRANSMISSION; EPIDEMIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PREVALENCE; PREVENTIVE HEALTH SERVICE; SUBSTANCE ABUSE; UNITED STATES;

EPIDEMICS; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; NEEDLE-EXCHANGE PROGRAMS; NEW YORK CITY; PREVALENCE; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 79951558996     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826084.2011.521456     Document Type: Article

References (55)

1. Anderson, W.(1991).The New York needle trial: The politics of public health in the age of AIDS.American Journal of Public Health, 81, 1506-1517.
2. Bennani, Y., Forgione, L., & Torian, L.(2007).HIV incidence estimates using STARHS over the first four and one-half years of named HIV reporting in NYC, 2000-2004.Paper presented at the 14th Conference on Retroviruses & Opportunistic Infections, Los Angeles, CA.
3. Casriel, C., Des Jarlais, D.C., Rodriguez, R., Friedman, S.R., Stepherson, B., & Khuri, E.(1990).Working with heroin sniffers: Clinical issues in preventing drug injection.Journal of Substance Abuse Treatment, 7, 1-10. (Pubitemid 20194561)
4. Casriel, C., Rockwell, R., & Stepherson, B.(1988).Heroin sniffers: Between two worlds.Journal of Psychoactive Drugs, 20, 437-440. (Pubitemid 19047398)
5. Centers for Disease Control and Prevention.(1981).Pneumocystis pneumonia-Los Angeles.Morbidity and Mortality Weekly Report,30, 250-252.
6. Craib, K., Spittal, C.,Wood, E., Laliberte, N., Hogg, R., Li, K., et al.(2003).Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver.Canadian Medical Association Journal, 168, 19-24. (Pubitemid 36241176)
7. Des Jarlais, D.C., Arasteh, A., Hagan, H., McKnight, C., Perlman, D., & Friedman, S.R.(2009).Persistence and change in disparities in HIV infection among injecting drug users in New York City after large-scale syringe exchange.American Journal of Public Health, 99(Suppl.2), S445-S451.
8. Des Jarlais, D.C., Arasteh, K., McKnight, C., Hagan, H., Perlman, D.,&Friedman, S.R.(2009).Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City.Drug and Alcohol Dependence, 101, 88-91.
9. Des Jarlais, D.C., Arasteh, K., Perlis, T., Hagan, H., Abdul-Quader, A., Heckathorn, D., et al.(2007).Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City: A new stage in a very large HIV epidemic.AIDS, 21, 231-235. (Pubitemid 46036932)
10. Des Jarlais, D.C., Arasteh, K., Perlis, T., Hagan, H., Heckathorn, D., McKnight, C., et al.(2007).The transition from injection to non-injection drug use: Long-term outcomes among heroin and cocaine users in New York City.Addiction, 102, 778-785. (Pubitemid 46633361)
11. Des Jarlais, D.C., Hagan, H., Friedman, S.R., Friedmann, P., Goldberg, D., Frischer, M., et al.(1995).Maintaining low HIV seroprevalence in populations of injecting drug users.Journal of the American Medical Association, 274, 1226-1231.
12. Des Jarlais, D.C., Casriel, C., Friedman, S.R., & Rosenblum, A.(1992).AIDS and the transition to illicit drug injection: Results of a randomized trial prevention program.British Journal of Addiction, 87, 493-498.
13. Des Jarlais, D.C., Choopanya, K., Vanichseni, S., Plangsringarm, K., Sonchai,W., Carballo,M., et al.(1994).AIDS risk reduction and reduced HIV seroconversion among injection drug users in Bangkok.American Journal of Public Health, 84, 452-455. (Pubitemid 24107832)
14. Des Jarlais, D.C., Friedman, S.R., & Hopkins, W.(1985).Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users.Annals of Internal Medicine, 103, 755-759. (Pubitemid 16218400)
15. Des Jarlais, D.C., Friedman, S.R., Novick, D.M., Sotheran, J.L., Thomas, P., Yancovitz, S., et al.(1989).HIV-1 infection among intravenous drug users inManhattan, New York City, from 1977 through 1987.Journal of the American Medical Association, 261, 1008-1012. (Pubitemid 19054147)
16. Des Jarlais, D.C., & Hopkins, W.(1985)."Free" needles for intravenous drug users at risk for AIDS: Current developments in New York City.New England Journal of Medicine, 313, 1476. (Pubitemid 16212332)
17. Des Jarlais, D.C.,Marmor,M., Friedmann, P., Aviles, E., Deren, S., Torian, L.V., et al.(2000).HIV incidence among injecting drug users in New York City, 1992-1997: Evidence for a declining epidemic.American Journal of Public Health, 90, 352-359. (Pubitemid 30115408)
18. Des Jarlais, D.C., Perlis, T., Arasteh, K., Hagan, H., Milliken, J., Braine, N., et al.(2004)."Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001.Journal of Acquired Immune Deficiency Syndromes, 35, 158-166. (Pubitemid 38133740)
19. Des Jarlais, D.C., Perlis, T., Arasteh, K., Torian, L.V., Beatrice, S., Milliken, J., et al.(2005).HIV incidence among injection drug users in New York City, 1990 to 2002: Use of serologic test algorithm to assess expansion of HIV prevention services.American Journal of Public Health, 95, 1439-1444. (Pubitemid 41060542)
20. Des Jarlais, D.C., Perlis, T., Friedman, S.R., Chapman, T., Kwok, J., Rockwell, R., et al.(2000).Behavioral risk reduction in a declining HIV epidemic: Injection drug users in New York City, 1990-1997.American Journal of Public Health, 90, 1112-1116. (Pubitemid 30445366)
21. Des Jarlais, D.C., Perlis, T., Friedman, S.R., Deren, S., Chapman, T.F., Sotheran, J.L., et al.(1998).Declining seroprevalence in a very large HIV epidemic: Injecting drug users in New York City, 1991 to 1996.American Journal of Public Health, 88, 1801-1806. (Pubitemid 29017995)
22. Diaz, T., Des Jarlais, D.C., Vlahov, D., Perlis, T.E., Edwards, V., Freidman, S.R., et al.(2001).Factors associated with prevalent hepatitis C virus infection: Differences among young adult injection drug users in lower and upper Manhattan, New York City.American Journal of Public Health, 91, 23-30. (Pubitemid 32049262)
23. Edlin, B.R., Irwin, K.L., Faruque, S., McCoy, C.B., Word, C., Serrano, Y., et al.(1994).Intersecting epidemics: Crack cocaine use and HIV infection among inner-city young adults.New England Journal of Medicine, 331, 1422-1427.
24. Friedman, S.R., Jose, B., Deren, S., Des Jarlais, D.C., Neaigus, A., & National AIDS Consortium.(1995).Risk factors for HIV seroconversion among out-of-treatment drug injectors in high and low-seroprevalence cities.American Journal of Epidemiology, 142, 864-874.
25. Friedman, S.R., Quimby, R.E., Sufian, M., Abdul-Quader, A., & Des Jarlais, D.C.(1988).Racial aspects of the AIDS epidemic.California Sociologist, Winter-Summer, 55-68.
26. Friedman, S.R., Sotheran, J.L., Abdul-Quader, A., Primm, B.J., Des Jarlais, D.C., Kleinman, P., et al.(1987).The AIDS epidemic among Blacks and Hispanics.Milbank Quarterly, 65, 455-499.
27. Friedman, S.R., Sufian,M., & Des Jarlais, D.C.(1990).The AIDS epidemic among latino intravenous drug users.In R.Glick & J.Moore (Eds.), Drugs in Hispanic communities (pp.45-54).New Brunswick, NJ: Rutgers University Press.
28. Friedman, S.R., Tempalski, B., Cooper, H., Perlis, T., Keem, M., Friedman, R., et al.(2004).Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users.Journal of Urban Health, 81, 377-400. (Pubitemid 39128276)
29. Hogg, R., Strathdee, S., Kerr, T., Wood, E., & Remis, R.(2005).HIV prevalence among Aboriginal British Columbians.Harm Reducion Journal, 2, 26-31
30. Department of Health and Mental Hygiene.(2006).New York City health.New York: Author.
31. Kaplan, E.H., & Heimer, R.(1992).A model-based estimate of HIV infectivity via needle sharing.Journal of Acquired Immune Deficiency Syndromes, 5, 1116-1118.
32. Kral, A.H., Bluthenthal, R.N., Lorvick, J., Gee, L., Bacchetti, P., & Edlin, B.R.(2001).Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: Risk-factor analysis.Lancet, 357, 1397-1401. (Pubitemid 32455367)
33. Li,W.,Kennedy, J.,Kelley, D., Sun,Y.,Maduro, G., Curry,A., et al.(2008).Summary of vital statistics 2007: The city of New York.New York: New York City Department of Health and Mental Hygiene, Statistical Analysis and Reporting Unit and Research and Surveillance Unit of the Bureau of Vital Statistics
34. Marmor, M., Des Jarlais, D.C., Cohen, H., Friedman, S.R., Beatrice, S.T., Dubin, N., et al.(1987).Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City.AIDS, 1, 39-44. (Pubitemid 18048273)
35. Marmor, M., Titus, S., Wolfe, H., Kransinski, K., Maslansky, R., Simberkoff, M., et al.(1994).Preparation for AIDS vaccine trials: Retention, behavior change, and HIV-seroconversion among injecting drug users (IDUs) and sexual partners of IDUs.AIDS Research and Human Retroviruses, 10, S207-S213. (Pubitemid 24375467)
36. Maslow, C.B., Friedman, S.R., Perlis, T.E., Rockwell, R., & Des Jarlais, D.C.(2002).Changes in HIV seroprevalence and related behaviors among male injection drug users who do and do not have sex with men: New York City, 1990-1999.American Journal of Public Health, 92, 382-384. (Pubitemid 34184824)
37. Nash, D., Bennani, Y., Ramaswamy, C., & Torian, L.V.(2005).Estimates of HIV incidence among persons testing for HIV using the sensitive/less sensitive enzyme immunoassay, New York City, 2001.Journal of Acquired Immune Deficiency Syndromes, 39, 102-111 (Pubitemid 40617025)
38. National Commission on AIDS.(1991).Full report: The twin epidemics of substance use and HIV.Washington, DC: Dogwood Center.
39. Neaigus, A., Atillasoy, A., Friedman, S.R., Andrade, X., Miller, M., Ildefonso, G., et al.(1998).Trends in the non-injected use of heroin and factors associated with the transition to injecting.In J.Inciardi & L.D.Harrison (Eds.),Heroin in the age of crack cocaine (pp.131-159).Thousand Oaks, CA: Sage.
40. Neaigus, A., Gyarmathy, V., Miller, M., Frajzyngier, V., Friedman, S.R., & Des Jarlais, D.C.(2006).Transitions to injecting drug use among noninjecting heroin users: Social network influence and individual susceptibility.Journal of Acquired Immune Deficiency Syndromes, 41, 493-503.
41. Neaigus, A., Sufian, M., Friedman, S.R., Goldsmith, D., Stepherson, B., Mota, P., et al.(1990).Effects of outreach intervention on risk reduction among intravenous drug users.AIDS Education and Prevention, 2, 253-271.
42. Nelson, K.E., Vlahov, D., Solomon, L., Cohn, S., & Munoz, A.(1995).Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, MD.Archives of Internal Medicine, 155, 1305-1311.
43. Novick, D.M., Trigg, H.L., Des Jarlais, D.C., Friedman, S.R., Vlahov, D., & Kreek, M.J.(1989).Cocaine injection and ethnicity in parenteral drug users during the early years of the human immunodeficiency virus (HIV) epidemic in New York City.Journal of Medical Virology, 29, 181-185. (Pubitemid 20006347)
44. Rockwell, R., Des Jarlais, D.C., Friedman, S.R., Perlis, T., & Paone, D.(1999).Geographic proximity, policy and utilization of syringe exchange programmes.AIDS Care, 11, 437-442. (Pubitemid 29349206)
45. Ryan, C., Elliott, J., Middleton, T., Mijch, A., Street, A., Hellard, M., et al.(2004).The molecular epidemiology of HIV type 1 among Vietnamese Australian injecting drug users in Melbourne, Australia.AIDS Research and Human Retroviruses, 20, 1364-1367. (Pubitemid 40065933)
46. Siddiqui, N.S., Brown, L.S., Meyer, T.J., & Gonzalez, V.(1993).Decline in HIV-1 seroprevalence and low seroconversion rate among injecting drug users at a methadone maintenance program in New York City.Journal of Psychoactive Drugs, 25, 245-250. (Pubitemid 23298779)
47. Spira, T., Des Jarlais, D.C., Marmor, M., Yancovitz, S., Friedman, S.R., Garber, J., et al.(1984).Prevalence of antibody to lymphadenopathy-associated virus among drugdetoxification patients in New York.New England Journal of Medicine, 311, 467-468.
48. Stoneburner, R., Des Jarlais, D.C., Benezra, D., Singh, T., Sotheran, J.L., Friedman, S.R., et al.(1988).A larger spectrum of severe HIV-1-related disease in intravenous drug users in New York City.Science, 242, 916-919. (Pubitemid 19015252)
49. Strathdee, S.A., & Sherman, S.G.(2003).The role of sexual transmission of HIV infection among injection and non-injection drug users.Journal of Urban Health, 80, iii7-iii14.
50. UNAIDS/WHO.(2007).AIDS epidemic update: December 2006.Geneva: Author.
51. Uuskula, A., McNutt, L., Dehovitz, J., Fischer, K., & Heimer, R.(2007).High prevalence of blood-borne virus infections and high-risk behaviour among injecting drug users in Tallinn, Estonia.International Journal of STD and AIDS, 18, 41-46.
52. Van Den Berg, C., Smit, C., Van Brussel, G., Coutinho, R., & Prins, M.(2007).Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: Evidence from the Amsterdam Cohort Studies among drug users.Addiction, 102, 1454-1462. (Pubitemid 47246988)
53. Vlahov,D., Anthony, J.C.,Munoz,A., Margolick, J., Nelson, K.E., Celentano, D.D., et al.(1991).The Alive Study: A longitudinal study of HIV-1 infection in intravenous drug users: Description of methods.Journal of Drug Issues, 21, 759-776.
54. Wood, E., Lloyd-Smith, E., Li, K., Strathdee, S., Small, W., Tyndall, M., et al.(2007).Frequent needle exchange use and HIV incidence in Vancouver, Canada.American Journal of Medicine, 120, 172-179. (Pubitemid 46175770)
55. Zhang, Y., Shan, H., Trizzino, J., Ruan, Y., Beauchamp, G., Masse, B., et al.(2007).Demographic characteristics and risk behavior associated with HIV positive injecting drug users in Xinjiang, China.Journal of Infection, 54, 285-290. (Pubitemid 46238173)